Skip to Main Content

Paper Details

Clinical outcomes of HIV-1 infected patients switched from complex multi-tablet regimens to tenofovir alafenamide based single-tablet regimens plus a boosted protease inhibitor in a real-world setting.
Journal of Virus Eradication
2
2020
ADRs, Adverse, DRV, HIV, HIV-1, HIV-1 RNA, HIV-1 RNA50, HIV-1 infected, MTR, RPV, RPV/, TAF, cobicistat, darunavir, elvitegravir, emtricitabine, patients, rilpivirine, ritonavir, tenofovir alafenamide, tenofovir-al, tenofovir-alafenamide
Author NameAffiliation
Edwin DeJesus
Edwin DeJesusUniversity of Central Florida College of Medicine
  • 1 - 2

Datasets

Release 1.2